BioCentury
ARTICLE | Distillery Techniques

Techniques: A gadolinium/CREKA (Cys-Arg-Glu-Lys-Ala) peptide-based MRI agent for detection of micrometastases

August 27, 2015 7:00 AM UTC

A gadolinium/CREKA-based MRI agent could help detect micrometastases of breast cancer, which have expression of fibronectin 1 (FN1; FN). The agent consisted of three molecules of a complex of gadolini...